Sanofi Genzyme

Sanofi-Genzyme (Genzyme) was a corporation based in Cambridge, Massachusetts. Established in 1981, the firm was the venture capital arm of Sanofi. Previously known as Genzyme Ventures, it has an expanded mandate to invest across the broad business footprint of Sanofi. The firm only invested in early-stage companies with promising new products that may be future Sanofi pipeline candidates. The firm was focused on rare diseases, rare blood disorders, multiple sclerosis, oncology, and immunology. The assets of the firm were managed by the executive management team. The firm was acquired by Sanofi.